Complete FDA and NHTSA recall records dated in April 2024.
These records include useful source details for the selected month.
During an inspection by NCDA, the firm was notified that the label does not list the sub ingredients for their products.
Undeclared Milk, Wheat, & Soy due to incorrect ingredient label
On 03/30, TFSW ALBSWY CHICKEN CAESAR SALAD 10OZ (Egg, F-Anchovy, Milk, Soy, Wheat) was mislabeled with undeclared allergens as ALBSWY GARDEN SALAD 17OZ (Milk, Wheat)
During an inspection by NCDA, the firm was notified that the label fails to list any sub ingredients.
During an inspection by NCDA, the firm was notified that the label does not list any ingredients in the product.
During an inspection by NCDA, the firm was notified that the label fails to declare the allergen soy as an ingredient. The firm was also notified that the label does not list any sub…
Due to elevated levels of lead in ground cinnamon
Undeclared Wheat, Soy, Egg, Milk, Tree Nuts (foreign language labeling)
The "Alipotec King" Alipotec Raiz de Tejocote product was found to contain toxic yellow oleander instead of tejocote.
During an inspection by NCDA, the firm was notified that the label does not list the sub ingredients for their products.
Tuna salad sandwich was mislabeled as an egg salad sandwich. There is an undeclared allergen of fish (Tuna).
During an inspection by NCDA, the firm was notified that the product label fails to list any ingredients.
Superpotent Drug: The 3-month stability result for assay was found to be above specification limit
CGMP Deviations
Ford Motor Company (Ford) is recalling certain 2021-2024 Bronco Sport and 2022-2023 Maverick vehicles. The body and power train control modules may fail to detect a change in the 12-volt…
Ford Motor Company (Ford) is recalling certain 2024 Maverick vehicles. The tire and loading information label may state the incorrect vehicle capacity, tire pressure, and spare tire size.…
Product may have a weak seal which may result in a breach of sterility of the contents if the seal fails. The weak seal may not be detectable by all users.
The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did…
Product may have a weak seal which may result in a breach of sterility of the contents if the seal fails. The weak seal may not be detectable by all users.
Product may have a weak seal which may result in a breach of sterility of the contents if the seal fails. The weak seal may not be detectable by all users.
Product may have a weak seal which may result in a breach of sterility of the contents if the seal fails. The weak seal may not be detectable by all users.
The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did…
Products were found to have confirmed drug cross contamination prior to release may lead to incorrect, inadequate, or absent antibiotic treatment or delay in results
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
